“It is accepted that the introduction of these new standards will affect the assessment (inspection) process” 7– 9 These documents were adopted as source references (section 3). The new standards were drafted to be in conformity with several documents that were either published 5, 6 or in the process of being revised and published. At the outset the SRG established several guiding principles. This main group met on nine occasions with a subgroup undertaking editorial work. Members of the SRG were drawn from the main laboratory professions and from all the major disciplines of pathology. This will require retraining of the current inspectors and the recruitment of new ones. Assessors will need to understand and be able to assess a quality management system, in addition to the professional aspects of the functioning of a medical laboratory. It is accepted that the introduction of these new standards will affect the assessment (inspection) process. After this consultation and revision the new standards were approved by the board of CPA on 8 December 2000 and published on the CPA website in January 2001. The SRG first met in September 1998 and draft standards went to the shareholders of CPA for consultation in April 2000. ![]() First, that in the light of changes taking place in international standards, a standards revision group (SRG) should be established to review existing standards and, second, that CPA should seek to operate in conformity with international standards such as ISO guide 58 2 or Standards for health care accreditation bodies. As a result of this development, the board of CPA commissioned an internal report that made two main recommendations. In 1996, the first drafts of a new international standard, ISO 15189 Quality management in the medical laboratory were circulated. Since its incorporation in January 1992, Clinical Pathology Accreditation (UK) Ltd (CPA) has, with some modification, used standards 1 based on the laboratory sections of the Canadian, Australian, and UK standards for healthcare.
0 Comments
Leave a Reply. |